Rajiv Mahadevan

Rajiv Mahadevan has a diverse work experience spanning multiple industries. Rajiv is currently the CEO of Attune Neurosciences, Inc., a position they have held since April 2020. Prior to that, they co-founded and served as the CEO of Applied Immunology, which was later acquired by Precision Medicine Group. During their time at Precision Medicine Group, Rajiv held the position of Managing Director from May 2016 to March 2020.

In addition to their roles in the biotech and healthcare sectors, Rajiv has also been involved in various entrepreneurial ventures. Rajiv co-founded Tactile Therapeutics, Inc. in January 2021 and was a member of Aliso Ventures since July 2019. Rajiv also served as a member of the Board of Directors at Bionure, a clinical stage biotech company, from January 2018 to August 2019.

Before their involvement in the biotech and entrepreneurial sectors, Rajiv gained experience in business development and strategy roles. Rajiv worked at companies such as 23andMe and Novo Nordisk A/S, where they focused on business development, licensing, and strategic operations.

Rajiv Mahadevan's expertise and experience in the biotech, healthcare, and business development fields make him a well-rounded professional in the industry.

Rajiv Mahadevan completed their BA in Molecular & Cell Biology at the University of California, Berkeley from 1993 to 1997. Afterward, they pursued an MBA at the Stanford University Graduate School of Business, graduating between 2001 and 2003.